Transaction DateRecipientSharesTypePriceValue
30th September 2020Capital, Llc Armistice0Open or private sale$0.00
30th September 2020Capital, Llc Armistice5,500Open or private sale$0.13$715.00
29th September 2020Capital, Llc Armistice0Open or private sale$0.00
29th September 2020Capital, Llc Armistice5,000Open or private sale$0.14$700.00
28th September 2020Capital, Llc Armistice0Open or private sale$0.00
28th September 2020Capital, Llc Armistice4,966Open or private sale$0.13$645.58
24th September 2020Capital, Llc Armistice38,257Open or private sale$0.13$4,973.41
24th September 2020Capital, Llc Armistice0Open or private sale$0.00
23rd September 2020Capital, Llc Armistice0Open or private sale$0.00
23rd September 2020Capital, Llc Armistice1,000Open or private purchase$3.91$3,910.00
Bio Path Holdings
Bio Path Holdings logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.


Bio-Path Holdings, Inc. is a biotechnology company. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007.


Ticker: BPTH
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1133818
Employees: 9
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals